stoxline Quote Chart Rank Option Currency Glossary
  
(UTMD)
  0 (0%)    09-27 11:14
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-09-26 4:52:15 PM
Short term     
Mid term     
Targets 6-month :  75 1-year :  87.61
Resists First :  64.22 Second :  75
Pivot price 62.57
Supports First :  59.11 Second :  55.95
MAs MA(5) :  62.88 MA(20) :  62.47
MA(100) :  57.52 MA(250) :  59.59
MACD MACD :  0.9 Signal :  1
%K %D K(14,3) :  57.9 D(3) :  62.3
RSI RSI(14): 56.3
52-week High :  68.98 Low :  51.25
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ UTMD ] has closed below upper band by 40.9%. Bollinger Bands are 40.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 63.43 - 63.81 63.81 - 64.18
Low: 61.29 - 61.74 61.74 - 62.18
Close: 62.12 - 62.78 62.78 - 63.42
Company Description

Headline News

Tue, 16 Sep 2025
Recap Report: Is UTMD forming a bullish divergence - Weekly Profit Summary & Community Trade Idea Sharing Platform - خودرو بانک

Wed, 30 Jul 2025
UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3% - The Globe and Mail

Tue, 29 Jul 2025
Utah Medical Products Boosts Shareholder Returns: Announces 1.7% Dividend Increase for Q3 2025 - Stock Titan

Sun, 27 Jul 2025
What are analysts’ price targets for UTMD in the next 12 months - Invest smarter with actionable market insights - Jammu Links News

Wed, 09 Jul 2025
pH-sensitive fibronectin nanogels combined with UTMD for anti-atherosclerosis treatment through anti-inflammatory and antioxidant effects - ScienceDirect.com

Thu, 03 Jul 2025
Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 3 (M)
Shares Float 3 (M)
Held by Insiders 7.1 (%)
Held by Institutions 71.3 (%)
Shares Short 110 (K)
Shares Short P.Month 111 (K)
Stock Financials
EPS 3.75
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 36.54
Profit Margin 32.3 %
Operating Margin 34.9 %
Return on Assets (ttm) 6.9 %
Return on Equity (ttm) 10.3 %
Qtrly Rev. Growth -4.4 %
Gross Profit (p.s.) 6.93
Sales Per Share 12.09
EBITDA (p.s.) 5.25
Qtrly Earnings Growth -4 %
Operating Cash Flow 14 (M)
Levered Free Cash Flow 11 (M)
Stock Valuations
PE Ratio 16.74
PEG Ratio 0
Price to Book value 1.71
Price to Sales 5.19
Price to Cash Flow 14.26
Stock Dividends
Dividend 0.31
Forward Dividend 0
Dividend Yield 0.4%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android